Resultados: 4

Research priorities for the secondary prevention and management of acute rheumatic fever and rheumatic heart disease: a National Heart, Lung, and Blood Institute workshop report

BMJ glob. health; 8 (9), 2023
Secondary prevention of acute rheumatic fever (ARF) and rheumatic heart disease (RHD) involves continuous antimicrobial prophylaxis among affected individuals and is recognised as a cornerstone of public health programmes that address these conditions. However, several important scientific issues around ...

Persisting burden and challenges of rheumatic heart disease

Eur. heart j; 42 (34), 2021
Rheumatic heart disease (RHD) is the result of episodes of acute rheumatic fever with valvular (and other cardiac) damage caused by an abnormal immune response to group A streptococcal infections, usually during childhood and adolescence. As a result of improved living conditions and the introduction of ...

Out-of-pocket costs in rheumatic heart disease care: A major barrier to equity in cardiovascular health

Indian heart j; 73 (2021), 2021
Rheumatic heart disease (RHD) results from untreated and often repetitive episodes of Rheumatic Fever (RF), which in turn is caused by uncontrolled group A beta-hemolytic streptococcal (GAS) infection in a susceptible host. In endemic areas for RHD the disease starts during childhood or adolescence, thus...

Rheumatic heart disease in Africa: is there a role for genetic studies?

Cardiovasc. j. Afr; 2 (26), 2015
Rheumatic heart disease (RHD) constitutes a leading cause of premature death and incapacity in Africa, where it is encountered in younger people, and shows a much faster and more malignant course than that seen in Europe or North America. While it is well established that RHD is a consequence of recurren...